Diphosphate (BioCAD00000010207)
blood saliva urine epidermis fibroblasts intestine neuron platelet prostate skeletal muscle testis
Metabolite Card
Formula: H4P2O7 (177.9432)
SMILES: OP(O)(=O)OP(O)(O)=O
Synonyms [en]
pyrophosphate; pyrophosphoric acid; diphosphoric acid; H4P2O7; Diphosphorsaeure; acide diphosphorique
Last reviewed on 2024-06-28.
Cite this Page
Diphosphate. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000010207). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
The anion, the salts, and the esters of pyrophosphoric acid are called pyrophosphates. The pyrophosphate anion is abbreviated PPi and is formed by the hydrolysis of ATP into AMP in cells. This hydrolysis is called pyrophosphorolysis. The pyrophosphate anion has the structure P2O74-, and is an acid anhydride of phosphate. It is unstable in aqueous solution and rapidly hydrolyzes into inorganic phosphate. Pyrophosphate is an osteotoxin (arrests bone development) and an arthritogen (promotes arthritis). It is also a metabotoxin (an endogenously produced metabolite that causes adverse health affects at chronically high levels). Chronically high levels of pyrophosphate are associated with hypophosphatasia. Hypophosphatasia (also called deficiency of alkaline phosphatase or phosphoethanolaminuria) is a rare, and sometimes fatal, metabolic bone disease. Hypophosphatasia is associated with a molecular defect in the gene encoding tissue non-specific alkaline phosphatase (TNSALP). TNSALP is an enzyme that is tethered to the outer surface of osteoblasts and chondrocytes. TNSALP hydrolyzes several substances, including inorganic pyrophosphate (PPi) and pyridoxal 5'-phosphate (PLP), a major form of vitamin B6. When TSNALP is low, inorganic pyrophosphate (PPi) accumulates outside of cells and inhibits the formation of hydroxyapatite, one of the main components of bone, causing rickets in infants and children and osteomalacia (soft bones) in adults. Vitamin B6 must be dephosphorylated by TNSALP before it can cross the cell membrane. Vitamin B6 deficiency in the brain impairs synthesis of neurotransmitters which can cause seizures. In some cases, a build-up of calcium pyrophosphate dihydrate crystals in the joints can cause pseudogout.
DBLinks
- CAS Registry Number: 2466-09-3
- PubChem CID: 1023
- ChEBI: 18361
- HMDB: HMDB0000250
- LipidMaps:
- KEGG: C00013
- BioCyc:
- NCBI MeSH: diphosphoric acid
- Wikipedia: Pyrophosphate
Other DBLinks
- CAS Registry Number: 14000-31-8
- CAS Registry Number: 2466-09-3
- CAS Registry Number: 33943-49-6
- PubChem: 1023
- ChEBI: ChEBI:18361
- ChEBI: ChEBI:29888
- HMDB: HMDB0000250
- HMDB: HMDB00250
- KEGG: C00013
- NCBI MeSH: diphosphoric acid
- Wikipedia: Pyrophosphate
- Wikipedia: Pyrophosphoric_acid
- DrugBank: DB04160
- MoNA: FiehnLib000831
- MoNA: FiehnLib000923
- MoNA: FiehnLib000924
- MoNA: HMDB0000250_c_ms_99515
- MoNA: HMDB0000250_c_ms_99516
- MoNA: HMDB0000250_ms_ms_1218082
- MoNA: HMDB0000250_ms_ms_1218083
- MoNA: HMDB0000250_ms_ms_1218084
- MoNA: OUF00438
- Metlin: METLIN_3306
- Coconut NaturalProduct: CNP0358887.0
Class / Ontology
- WishartLab ClassyFire: [Non-metal pyrophosphates] Non-metal pyrophosphates
- ChEBI: [CHEBI:29888] diphosphoric acid
| ID | EC Number | Name |
|---|---|---|
| KEGG:R00004 | 3.6.1.1 | diphosphate phosphohydrolase; |
| KEGG:R00012 | 2.7.7.45 | GTP:GTP guanylyltransferase |
| KEGG:R00087 | 3.6.1.8 | ATP diphosphohydrolase (diphosphate-forming); |
| KEGG:R00089 | 4.6.1.1 | ATP diphosphate-lyase (cyclizing; 3',5'-cyclic-AMP-forming) |
| KEGG:R00137 | 2.7.7.1 | ATP:nicotinamide-nucleotide adenylyltransferase |
| KEGG:R00138 | 3.6.1.25 | triphosphate phosphohydrolase |
| KEGG:R00161 | 2.7.7.2 | ATP:FMN adenylyltransferase |
| KEGG:R00177 | 2.5.1.6 | ATP:L-methionine S-adenosyltransferase |
| KEGG:R00189 | 6.3.1.5 | deamido-NAD+:ammonia ligase (AMP-forming) |
| KEGG:R00190 | 2.4.2.7 | AMP:diphosphate phospho-D-ribosyltransferase |
| KEGG:R00206 | 2.7.9.1 | ATP:pyruvate,phosphate phosphotransferase |
| KEGG:R00235 | 6.2.1.1 | acetate:CoA ligase (AMP-forming) |
| KEGG:R00257 | 6.3.5.1 | deamido-NAD+:L-glutamine amido-ligase (AMP-forming) |
| KEGG:R00289 | 2.7.7.9 | UTP:alpha-D-glucose-1-phosphate uridylyltransferase |
| KEGG:R00316 | 6.2.1.1 | ATP:acetate adenylyltransferase |
| KEGG:R00320 | 2.7.2.12 | diphosphate:acetate phosphotransferase |
| KEGG:R00336 | 3.1.7.2 | guanosine-3',5'-bis(diphosphate) 3'-diphosphohydrolase |
| KEGG:R00346 | 4.1.1.38 | diphosphate:oxaloacetate carboxy-lyase (transphosphorylating;phosphoenolpyruvate-forming); |
| KEGG:R00375 | 2.7.7.7 | deoxyadenosine 5'-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) |
| KEGG:R00376 | 2.7.7.7 | deoxyguanosine 5'-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-6138 | CMP-N-acetylneuraminate biosynthesis I (eukaryotes) |
| BioCyc:HUMAN_PWY-6121 | 5-aminoimidazole ribonucleotide biosynthesis |
| BioCyc:HUMAN_NAD-BIOSYNTHESIS-III | NAD salvage |
| BioCyc:HUMAN_PWY-4984 | urea cycle |
| BioCyc:HUMAN_PWY0-1313 | acetate conversion to acetyl-CoA |
| BioCyc:HUMAN_PWY0-1264 | biotin-carboxyl carrier protein assembly |
| BioCyc:HUMAN_PWY66-161 | oxidative ethanol degradation III |
| BioCyc:HUMAN_PWY-5661-1 | GDP-glucose biosynthesis II |
| BioCyc:HUMAN_PWY-5120 | geranylgeranyldiphosphate biosynthesis |
| BioCyc:HUMAN_PWY-7803 | tRNA splicing II |
| BioCyc:HUMAN_PWY66-401 | superpathway of tryptophan utilization |
| BioCyc:HUMAN_PWY-5667 | CDP-diacylglycerol biosynthesis |
| BioCyc:HUMAN_PWY-7592 | arachidonate biosynthesis III (metazoa) |
| BioCyc:HUMAN_PWY-6352 | 3-phosphoinositide biosynthesis |
| BioCyc:HUMAN_PWY-7888 | tRNA-uridine 2-thiolation (cytoplasmic) |
| BioCyc:HUMAN_ASPARAGINE-BIOSYNTHESIS | asparagine biosynthesis |
| BioCyc:HUMAN_PWY-6292 | cysteine biosynthesis |
| BioCyc:HUMAN_PWY-5328 | superpathway of methionine degradation |
| BioCyc:HUMAN_PWY-6823 | molybdenum cofactor biosynthesis |
| BioCyc:HUMAN_PWY66-388 | fatty acid α-oxidation III |